Exercise, Rehab Services Can Be Integrated Into Breast Cancer Care
By Lori Solomon HealthDay Reporter
MONDAY, April 28, 2025 -- Exercise and rehabilitation services for patients with breast cancer through a clinical workflow algorithm called CORE (Comprehensive Oncology Rehabilitation and Exercise) is feasible and acceptable to patients, according to a study published online April 28 in Cancer.
Lea Haverbeck Simon, Ph.D., from the Huntsman Cancer Institute at the University of Utah in Salt Lake City, and colleagues evaluated the feasibility and acceptability of the CORE clinical workflow algorithm. The analysis included 72 patients with newly diagnosed stage I to III breast cancer needing surgery as first-line treatment who were randomly assigned (2:1) to CORE or standard of care.
The researchers found that 93 percent of participants in CORE completed the triaging tool, demonstrating its feasibility. Among those triaged to a service pathway, 62 percent completed their referral. Focus groups provided primarily positive feedback.
"CORE may serve as a model workflow algorithm aimed to integrate both exercise and rehabilitation services from time of diagnosis and beyond," senior author Adriana M. Coletta, Ph.D., also from the Huntsman Cancer Institute, said in a statement. "Findings from this trial support national efforts led by the American College of Sports Medicine to integrate exercise and rehabilitation services as part of routine cancer care."
One author disclosed receiving personal/consulting fees from ImpediMed.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
CRC as First of Multiple Primary Malignancies Tied to Better Outcomes Than CRC as Only Malignancy
THURSDAY, June 26, 2025 -- Compared with colorectal cancer (CRC) presenting as an isolated primary or second primary malignancy, CRC presenting as the first of multiple primary...
Two-Hour Observation Probably Safe for Most Children With Anaphylaxis
THURSDAY, June 26, 2025 -- For most children who present to an emergency department with an acute allergic reaction requiring epinephrine, a two-hour observation period is...
CT Perfusion and CT Angiography Not Useful as Standalone Tests for Establishing Death by Neurologic Criteria
THURDAY, June 26, 2025 -- Neither computed tomography (CT) perfusion nor CT angiography meet the prespecified validation threshold as an ancillary test for death by neurologic...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.